Neurochem, Inc.
275 Armand-Frappier Boulevard
Laval
Quebec
H7V 4A7
Canada
Tel: 450-680-4500
Fax: 450-680-4501
Website: http://www.neurochem.com/
Email: webinfo@neurochem.com
67 articles about Neurochem, Inc.
-
Neurochem, Inc. Announces The Initiation Of An Open-Label Phase III Extension Study For Alzhemed(TM) In North America
2/8/2006
-
Neurochem, Inc. Enrolls First Patient In Phase III Clinical Trial For Alzheimer's Disease In Europe
11/22/2005
-
Neurochem, Inc. Closes Sale And Leaseback Transaction For Laval Facilities
11/18/2005
-
Neurochem, Inc. Reports Results For Third Quarter Of Fiscal 2005
11/9/2005
-
Neurochem, Inc. Announces Sale And Leaseback Transaction For Laval Facilities; Sale Price Of C$32 Million
11/9/2005
-
Neurochem, Inc. To Report On Third Quarter Of Fiscal 2005
11/8/2005
-
Neurochem, Inc. To Present At CIBC World Markets Sixteenth Annual Healthcare Conference
11/3/2005